Colorectal cancer is the third leading cause of cancer mortality in the U.S. The American Cancer Society estimates that this year alone, there will be 106,180 new cases of colon cancer diagnosed.
Two promising new studies have found that certain cannabinoids— including CBD, CBDV, CBG, CBGV, and CBL— can eliminate the growth of harmful colorectal cancer cells in humans. These studies offer a guiding light to those researching cannabinoids for cancer treatment, although they are limited in their scope.
THC was not able to be included in the research group in either study due to regulations that don’t allow certain scientists to study it. The
→ Continue reading at Forbes
